These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10754462)

  • 1. Comparison of cytosolic p53 protein levels in the female genital tract and breast, and their tumors.
    Westhof G; Bader W; Greiner-Mai E; Hatzmann W
    Tumour Biol; 2000; 21(3):123-34. PubMed ID: 10754462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.
    Borg A; Lennerstrand J; Stenmark-Askmalm M; Fernö M; Brisfors A; Ohrvik A; Stål O; Killander D; Lane D; Brundell J
    Br J Cancer; 1995 May; 71(5):1013-7. PubMed ID: 7734292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cytosolic p53 protein in breast cancer.
    Montero S; Guzmán C; Vargas C; Ballestín C; Cortés-Funes H; Colomer R
    Tumour Biol; 2001; 22(5):337-44. PubMed ID: 11553865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 determination in gynecological carcinomas: immunohistochemistry compared to luminometric immunoassay (LIA).
    Heinze T; Greiner-Mai E; Lichtenegger W
    Anticancer Res; 1999; 19(4A):2505-8. PubMed ID: 10470183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogen receptors in the genital tract of the climacteric woman].
    Pérez-López FR; Campo López C
    Rev Med Univ Navarra; 1991; 36(4):17-31. PubMed ID: 1821057
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.
    Levesque MA; Diamandis EP; Yu H; Sutherland DJ
    Breast Cancer Res Treat; 1994; 30(2):179-95. PubMed ID: 7524772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metallothionein expression in normal endometrium and cancers of the uterus, ovary and breast].
    Schmid KW; Hittmair A; Tötsch M; Müller E; Zaimet A; Tauscher T; Dünser M; Ofner D
    Gynakol Rundsch; 1990; 30 Suppl 1():150-1. PubMed ID: 2079251
    [No Abstract]   [Full Text] [Related]  

  • 9. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of immunoreactive relaxin in the genital tract and in the mammary gland of non-pregnant women.
    Bongers-Binder S; Burgardt A; Seeger H; Voelter W; Lippert TH
    Clin Exp Obstet Gynecol; 1991; 18(3):161-4. PubMed ID: 1752047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].
    Casper F; Weikel W; Schaffrath M; Kuner RP; Hoffmann G; Pollow B; Pollow K
    Zentralbl Gynakol; 2000; 122(3):153-9. PubMed ID: 10756599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
    Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between p53 expression and other prognostic factors in human breast carcinoma. An immunohistochemical study.
    Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
    Am J Clin Pathol; 1993 Sep; 100(3):213-7. PubMed ID: 8379528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.
    Thor AD; Moore DH II; Edgerton SM; Kawasaki ES; Reihsaus E; Lynch HT; Marcus JN; Schwartz L; Chen LC; Mayall BH
    J Natl Cancer Inst; 1992 Jun; 84(11):845-55. PubMed ID: 1317462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers.
    Peyrat JP; Vanlemmens L; Fournier J; Huet G; Révillion F; Bonneterre J
    Clin Cancer Res; 1998 Jan; 4(1):189-96. PubMed ID: 9516970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein expression in human breast carcinoma: lack of prognostic potential for recurrence of the disease.
    Katoh A; Breier S; Stemmler N; Specht S; Blanock K; D'Amico F
    Anticancer Res; 1996; 16(3A):1301-4. PubMed ID: 8702254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 associated with cathepsin D in primary breast cancer.
    Marsigliante S; Leo G; Mottaghi A; Biscozzo L; Greco S; Storelli C
    Int J Clin Lab Res; 1993; 23(2):102-8. PubMed ID: 8518412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 accumulation in ovarian carcinomas and its prognostic implications.
    Bosari S; Viale G; Radaelli U; Bossi P; Bonoldi E; Coggi G
    Hum Pathol; 1993 Nov; 24(11):1175-9. PubMed ID: 8244317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 expression in breast cancer related to prognostic factors.
    Ciesielski D; Dziewulska-Bokiniec A; Zółtowska A; Roszkiewicz A; Kopacz A; Wojtacki J
    Neoplasma; 1995; 42(5):235-7. PubMed ID: 8552201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.